Bulletin
Investor Alert

Eli Lilly & Co.

NYS: LLY

GO
/marketstate/country/us

After Hours

LLY
/zigman2/quotes/200106384/composite

$

260.33

Change

-0.04 -0.02%

Volume

Volume 101,574

Nov 26, 2021, 4:58 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/200106384/composite

Previous close

$ 262.00

$ 260.37

Change

-1.63 -0.62%

Day low

Day high

$259.03

$265.88

Open
Open: 261.80

52 week low

52 week high

$143.13

$275.87

Open

Market cap

$249.07B

Average volume

2.64M

P/E ratio

39.75

Rev. per Employee

$701,137

EPS

6.55

Dividend

0.85

Div yield

1.31%

Ex dividend date

11/12/21

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/lly

MarketWatch News on LLY

  1. Eli Lilly stock price target raised to $301 from $262 at Truist

    7:16 a.m. Nov. 24, 2021

    - Tomi Kilgore

  2. Eli Lilly started at outperform with $311 stock price target at BMO Capital

    8:50 a.m. Nov. 19, 2021

    - Tomi Kilgore

  3. Pfizer CEO Talks About Covid Vaccines and What Comes Next

    2:26 p.m. Nov. 18, 2021

    - Josh Nathan-Kazis

  4. Tracking Tweets: 'Twitter Buzz' Index Launches

    11:51 a.m. Nov. 18, 2021

    - Avi Salzman

  5. Top Biogen Executive Announces Retirement as Aduhelm Rollout Stumbles

    10:31 a.m. Nov. 16, 2021

    - Josh Nathan-Kazis

  6. Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.

    10:03 p.m. Nov. 14, 2021

    - Josh Nathan-Kazis

  7. Eli Lilly Earnings Disappointed. Why the Stock Is Rising.

    2:09 p.m. Oct. 26, 2021

    - Joe Woelfel

  8. Eli Lilly Is Asking the FDA to Approve Its Alzheimer's Therapy

    11:47 a.m. Oct. 26, 2021

    - Josh Nathan-Kazis

  9. Eli Lilly shares up 1.2% premarket

    6:31 a.m. Oct. 26, 2021

    - Ciara Linnane

  10. Eli Lilly full-year FactSet consensus EPS $7.90; revenue $27.4 bln

    6:30 a.m. Oct. 26, 2021

    - Ciara Linnane

  11. Apple, Amazon, and Other Stocks to Watch This Week

    3:00 p.m. Oct. 24, 2021

    - Nicholas Jasinski

  12. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/lly

Other News on LLY

  1. Got $5,000? 2 Stocks to Buy and Hold Forever

    10:30 a.m. Nov. 24, 2021

    - Motley Fool

  2. Neurocrine Biosciences Gets Promising Drugs in Licensing Deal

    9:06 a.m. Nov. 24, 2021

    - GuruFocus.com

  3. Compass Pathways: Psychedelics For Mental Health

    4:24 p.m. Nov. 23, 2021

    - Seeking Alpha

  4. Is This Pharma Stock a Buy?

    7:45 a.m. Nov. 22, 2021

    - Motley Fool

  5. Novo Nordisk Gets A Bargain With Dicerna Acquisition

    10:48 a.m. Nov. 19, 2021

    - Seeking Alpha

  6. Will Pfizer's COVID Pill Crush the Hopes of Merck Investors?

    10:30 a.m. Nov. 19, 2021

    - Motley Fool

  7. Look to Big Pharma for Healthy Dividends

    3:39 p.m. Nov. 18, 2021

    - GuruFocus.com

  8. Loading more headlines...
/news/pressrelease/company/us/lly

Press Releases on LLY

  1. How the price action of Eli Lilly (LLY) is used to our Advantage

    9:12 p.m. Nov. 15, 2021

    - Stock Traders Daily

  2. Loading more headlines...

Rates »

Trending Tickers
  • /zigman2/quotes/200172674/composite EDSA+102.72%
  • /zigman2/quotes/209901640/composite SPY-1.67%
  • /zigman2/quotes/201343976/composite UVXY+16.31%
  • /zigman2/quotes/221104327/composite LCID+4.83%
  • /zigman2/quotes/214109287/composite SDC-3.13%
X
Powered by StockTwits
Link to MarketWatch's Slice.